Last update 08 May 2025

Fidia SpA

Public Company|1996|Italy|
100-250
| MIL: FDA|
www.fidia.it

Overview

Related

3
Drugs associated with Fidia SpA
Fiser-A607
Target-
Mechanism-
Active Org.-
Originator Org.
Fidia SpA
Active Indication-
Inactive Indication
Eye Diseases [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
Fiser-B102
Target-
Mechanism-
Active Org.-
Originator Org.
Fidia SpA
Active Indication-
Inactive Indication
Ocular inflammation
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
Fiser-A608
Target-
Mechanism-
Active Org.-
Originator Org.
Fidia SpA
Active Indication-
Inactive Indication
Ocular inflammation
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Fidia SpA
EUCTR2010-020513-87-IT
/ Not yet recruitingNot Applicable
A randomized, placebo-controlled, double-blind study on the intensity and duration of efficacy of sodium hyaluronate therapy (500-730 KDa) (HYALGAN) in the conservative treatment of Achilles tendinopathy. - ND
100 Clinical Results associated with Fidia SpA
Login to view more data
0 Patents (Medical) associated with Fidia SpA
Login to view more data
100 Deals associated with Fidia SpA
Login to view more data
100 Translational Medicine associated with Fidia SpA
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Fiser-A607
Infectious Diseases
More
Pending
Fiser-B102
Ocular inflammation
More
Pending
Fiser-A608
Ocular inflammation
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free